Russia Plans to Increase Tobacco Tax Rates by 2025

Regulations by 2FIRSTS.ai
Jul.04.2024
Russia Plans to Increase Tobacco Tax Rates by 2025
Russia plans to raise tobacco taxes by 4.7% in 2025, according to a second reading of the tax reform bill.

According to a report by TASS on July 3rd, the text of the second reading amendment to the Russian tax reform bill shows a plan to increase tobacco taxes by an average of 4.7% in 2025.


According to the amendment, the tax rates for cigarettes and cigars in 2025 are planned to increase to 2945 rubles per thousand (33.28 US dollars) plus 16% of the cost (not less than 4000 rubles [45.20 US dollars] per thousand), in 2026 to 3063 rubles (34.61 US dollars) plus 16% (not less than 4160 rubles [47 US dollars] per thousand), and in 2027 to 3186 rubles (36 US dollars) plus 16% (not less than 4326 rubles [48.88 US dollars] per thousand).


In addition, the plan is to increase the tobacco tax to 9,807 rubles per kilogram ($110.81) in 2025, potentially to 10,199 rubles ($115.24) in 2026, and to 10,607 rubles ($119.85) in 2027.


In addition, there are plans to increase the tax rate on e-cigarette liquid to 44 rubles (0.5 US dollars) per milliliter by 2025, 46 rubles (0.52 US dollars) by 2026, and 48 rubles (0.54 US dollars) by 2027.


The consumption tax is an indirect tax on domestic goods and services.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

IMiracle  Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide
IMiracle Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide
IMiracle announces significant R&D progress in 2025, with over 2,200 patent applications globally and 900 authorized patents.
Dec.18 by 2FIRSTS.ai
GEEKBAR Announces Restock on Social Media, Pulse and Pulse X Lines Back in Stock
GEEKBAR Announces Restock on Social Media, Pulse and Pulse X Lines Back in Stock
GEEKBAR has announced a new round of restocking across multiple overseas social media platforms, bringing its flagship Pulse and Pulse X product lines back on sale, with several previously hard-to-find flavors returning simultaneously, alongside the launch of the new Thermal Edition.
Dec.17 by 2FIRSTS.ai
iMiracle and VPR Reach Preliminary Settlement in ‘Elf’ Trademark Dispute, Potentially Ending Three-Year Legal Battle
iMiracle and VPR Reach Preliminary Settlement in ‘Elf’ Trademark Dispute, Potentially Ending Three-Year Legal Battle
According to Law360, VPR Brands and iMiracle have filed a joint notice in federal court in Florida stating that they have signed a settlement term sheet and plan to finalize a global settlement within 30 days that would resolve multiple lawsuits. The dispute, which began in 2022 and centers on the “Elf” trademark, has involved injunctions, counterclaims and a key ruling by the Federal Circuit overturning a lower court’s order.
Dec.11 by 2FIRSTS.ai
Illegal Vape Suppliers Move Online After Queensland Crackdown
Illegal Vape Suppliers Move Online After Queensland Crackdown
Less than two weeks after Queensland police raided and shut down tobacconists suspected of selling illegal e-cigarettes, at least one supplier has moved its business online. Flyers with QR codes advertising same-day delivery of vapes, tobacco, and nicotine pouches were found taped to electricity poles across the Gold Coast.
Dec.05 by 2FIRSTS.ai
Russian lawmakers propose total ban on e-cigarette sales, in response to Putin's call for protection of youth health
Russian lawmakers propose total ban on e-cigarette sales, in response to Putin's call for protection of youth health
Russian Duma members propose nationwide ban on e-cigarette sales in response to Putin's call for youth health protection.
Nov.28 by 2FIRSTS.ai
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai